Chunk #14 — Do cannabinoids cause short-lived positive psychotic symptoms, negative symptoms and cognitive deficits in the general population? — Experimental evidence
The pharmacological studies discussed so far had several limitations, including the absence of placebo control, lack of a double blind, the inclusion of psychiatrically ill individuals, and the lack of standardized measures of psychosis. Recently, there have been a few laboratory studies examining the psychotogenic effects of cannabinoids that address some of these limitations.
